Over 25 years | 10,000 horses | 100,000 tests | Accuracy guarantee*

Over 25 years | 10,000 horses | 100,000 tests | Accuracy guarantee*

Summer time! With heat, increased turnout time & socialising make sure you’re ahead of worms.

Prescribing the Right Dewormer Today Protects Horse Health Tomorrow

Anthelmintic resistance is no longer a future concern, it is already impacting the effectiveness of worming programmes across the UK. The decisions made today around parasite control will directly influence how effective treatments remain in the years ahead.

For horse owners, yards, and professionals, this means a shift away from routine, blanket worming and towards a more targeted, evidence-led approach.

Why Blanket Worming No Longer Works

Historically, many horses were wormed at fixed intervals regardless of need. While simple, this approach has accelerated resistance.

Within any parasite population, there are always a small number of worms with natural resistance to treatment. Repeated blanket dosing removes susceptible worms but allows resistant individuals to survive, reproduce, and gradually dominate the population.

Over time, this leads to:

  • Reduced drug efficacy

  • Increased treatment failures

  • Fewer reliable treatment options

With only a limited number of active ingredients available, preserving their effectiveness is critical.

The Core Principle: Targeted Treatment

Modern parasite control is built on a simple principle:

Only treat horses that need treating.

This is typically achieved through:

  • Faecal Egg Counts (FECs)

  • Tapeworm testing (saliva or blood-based)

  • Risk-based assessments (age, management, pasture exposure)

Targeted treatment:

  • Reduces unnecessary drug use

  • Slows resistance development

  • Maintains refugia (a population of non-resistant worms)

What Dewormers Are Available?

There are five key classes of anthelmintic used in horses:

  • Benzimidazoles (e.g. fenbendazole)

  • Tetrahydropyrimidines (e.g. pyrantel)

  • Macrocyclic lactones (e.g. ivermectin, moxidectin)

  • Praziquantel (tapeworm-specific)

  • Combination products (e.g. ivermectin + praziquantel)

Each has a specific spectrum of activity, and resistance patterns vary significantly between them.

Importantly:

  • Resistance to benzimidazoles and pyrantel is now widespread in small redworm populations

  • Early signs of reduced efficacy to macrocyclic lactones are emerging in some regions

Choosing the Right Treatment

Selecting the correct dewormer is not just about the product, it’s about context.

Key considerations include:

  • Which parasites are present

  • Egg shedding status (via FEC)

  • Horse age and risk profile

  • Time of year

  • Known resistance patterns

For example:

  • Roundworms (Parascaris spp.) are primarily a concern in foals and youngstock

  • Small redworms (cyathostomins) are the main focus in adult horses

  • Tapeworm requires specific testing and targeted treatment

Faecal egg counts are essential for identifying active shedders, but they do not detect all parasites – particularly encysted larvae or tapeworm reliably.

The Importance of Correct Dosing

Underdosing is one of the most significant drivers of resistance.

Best practice includes:

  • Accurately weighing the horse

  • Administering the full dose

  • Ensuring the full product is swallowed

Even small dosing inaccuracies can allow partially resistant worms to survive.

Sustainable Worm Control: The Bigger Picture

Effective parasite control is not just about treatments, it’s a system.

A sustainable programme includes:

  • Regular diagnostic testing

  • Strategic, not routine, worming

  • Good pasture management (e.g. poo picking, rotation)

  • Monitoring treatment efficacy

This approach protects:

  • The individual horse

  • The wider grazing population

  • The long-term effectiveness of available drugs

Encysted Redworm: A Targeted Approach

Encysted small redworm remains one of the most important health risks in horses, particularly during late autumn and winter.

However, routine blanket treatment for encysted stages is no longer recommended in all horses.

Instead:

  • Low-risk adult horses with consistently low FECs may not require treatment

  • Higher-risk horses should be assessed individually

  • Larvicidal treatments (e.g. moxidectin or 5-day fenbendazole where appropriate) should be used strategically

Risk assessment should consider:

  • Grazing pressure

  • Stocking density

  • Horse movement

  • Previous parasite history

Final Thought

The industry is at a turning point.

Continuing with outdated blanket worming practices will accelerate resistance and reduce treatment options. Moving towards evidence-based, targeted parasite control ensures we preserve what works…both now and for the future.

The goal is simple:

Use less, use smarter, and protect efficacy for the long term.

Leave a Reply

Your email address will not be published. Required fields are marked *